Literature DB >> 24965937

Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczema.

Julia Miyamoto1, Barbara C Böckle2, Detlef Zillikens3, Enno Schmidt3, Matthias Schmuth2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24965937     DOI： 10.1001/jamadermatol.2014.109

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  4 in total

Review 1.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

Review 2.  Systemic Agents for Severe Atopic Dermatitis in Children.

Authors:  Eliza R Notaro; Robert Sidbury
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

3.  Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; Beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrome after intra-articular glucocorticoid injection; troponin leak associated with drug-induced methemoglobinemia.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-01

Review 4.  Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

Authors:  Antonio Martinez-Lopez; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Am Acad Dermatol       Date:  2020-08-07       Impact factor: 11.527
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.